top of page

ABOUT US

hemotune_06_21_M5A0761.jpg
hemotune is a spin-off company originating out of the Functional Materials Lab at ETH Zurich. hemotune was founded in 2017 and is moving forward to redefine blood purification technology.
Vision

We envision a future where precision blood purification is an indispensable tool to improve patient outcomes and save lives in critical illness and beyond.

Mission

Our mission is to develop breakthrough blood purification technology, enabling revolutionary intervention strategies for the most urgent medical needs and making them accessible for the benefit of patients.

Values

Driven by impact, energized by passion. Leading for a better future with quality and innovation. United in teamwork, naturalizing integrity and diversity.

about the company
Team

MEET OUR MANAGEMENT TEAM

Our management team comes from different backgrounds and brings expertise in various fields. With their hands-on approach, they drive our day-to-day activities, ensure effective implementation of our plans, and lead the team that brings our revolutionary blood purification platform to life.

Lukas Langenegger
LinkedIn
Lukas Langenegger

CEO, Board Member and Co-founder

Bio
Team
Dr. Ursina Haltinner
LinkedIn
Dr. Ursina Haltinner

Head of Regulatory & Quality Affairs

Bio
Team
Dr. Carlos Mora
LinkedIn
Dr. Carlos Mora

CTO, Board Member and Co-founder

Bio
Team
Dr. Stephanie Sauter
LinkedIn
Dr. Stephanie Sauter

Head of Clinical Affairs

Bio
Team
Dr. Jean-Claude Metzger
LinkedIn
Dr. Jean-Claude Metzger

Head of Product Development

Bio
Team
Sami Abi Aad, MBA
LinkedIn
Sami Abi Aad, MBA

Head of Finance and Operations

Bio
Team

MEET THE TEAM

Team Description

DEPARTMENT

Team Description

Board

BOARD OF DIRECTORS

Our board of directors consists of visionary experts in pharmaceuticals, medical technology, and business. With board members who have excelled in corporate venture capital and successfully taken medtech startups to the stock exchange, our strategic leadership spearheads our journey towards revolutionizing blood purification and transforming patient care.

Perry-van-Rijsingen.jpg
Perry van Rijsingen

President of the Board

Didier_Cowling-2_edited_edited_edited_ed
Didier Cowling

Board Member

Markus_edited.jpg
Markus Goebel

Board Member

Lukas Langenegger

CEO & Board Member & Co-Founder

Dr. Carlos Mora

CTO & Board Member & Co-Founder

Clnical Advisory Board

CLINICAL ADVISORS

Our distinguished Medical Advisory Board uniquely combines key opinion leaders in blood purification, and sepsis, including treating physicians, clinical trial specialists, and experts in immunology and diagnostics. Their expertise guides our innovation, addressing critical medical needs and leveraging our breakthrough technology for patient benefit.

Schefold_Joerg_edited.jpg
Prof. Dr. Joerg C. Schefold

Clinical Advisory Board Chair

FMB_edited.jpg
Prof. Frank M. Brunkhorst

Clinical Advisory Board

Monneret3_edited_edited.jpg
Prof. Guillaume Monneret

Clinical Advisory Board

venet.jpg
Prof. Fabienne Venet

Clinical Advisory Board

singer2_edited.jpg
Prof. Mervyn Singer

Clinical Advisory Board

Advisors

SCIENTIFIC ADVISORS

Our scientific advisors provide invaluable guidance in harnessing the potential of
nanotechnology and materials science for our groundbreaking innovation in blood purification.
Their input fuels our research and development efforts, propelling us towards
transformative advancements in healthcare.

Stark_Wendelin_web©WyssZurich.jpg
Prof. Dr. Wendelin J. Stark

ETH Zurich

Grass_edited_edited_edited.jpg
Prof. Dr. Robert Grass

Turbobeads GmbH

Herrmann.JPG
Prof. Dr. Inge Herrmann

Empa & ETH Zurich

INVESTORS